Publications Database

Parikh M. , Kolevzon A. , Hollander E. (2008)

Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability

Journal of Child and Adolescent Psychopharmacology

April, 18(2), pp. 157-178

Read Abstract (New Window)

American Society of Health-System Pharmacists (2009)

Naltrexone.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

Posey D. J. , McDougle C. J. (2000)

The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders.

Harvard Review of Psychiatry

8(2), pp. 45-63

Read Abstract (New Window)

Rana F. , Gormez A. , Varghese S. (2013)

Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities.

Cochrane Database of Systematic Reviews

30(4),

Read Abstract (New Window) Read Full (New Window)

Rapp J. T. , Vollmer T. R. (2005)

Stereotypy II: a review of neurobiological interpretations and suggestions for an integration with behavioral methods.

Research in Developmental Disabilities

26(6), pp. 548-564

Read Abstract (New Window)

Riddle M. A. et al. (1999)

Anxiolytics, adrenergic agents, and naltrexone.

Journal of the American Academy of Child and Adolescent Psychiatry

38(5), pp. 546-556

Read Abstract (New Window)

Rossignol D. A. (2009)

Novel and emerging treatments for autism spectrum disorders: a systematic review.

Annals of Clinical Psychiatry

21(4), pp. 213-236

Read Abstract (New Window)

Roy A. et al. (2015)

Are opioid antagonists effective in reducing self-injury in adults with intellectual disability? A systematic review.

Journal of Intellectual Disability Research

January, 59(1), pp. 55-67.

Read Abstract (New Window)

Scahill L. , Koenig K. (1999)

Pharmacotherapy in children and adolescents with pervasive developmental disorders.

Journal of Child and Adolescent Psychiatric Nursing

12(1), pp. 41-43

Read Abstract (New Window)

Scifo R. et al. (1996)

Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone.

Annali dell'Istituto Superiore di Sanita

32(3), pp. 351-359

Read Abstract (New Window)

Symons F. J. , Thompson A. , Rodriguez M. (2004)

Self-injurious behavior and the efficacy of naltrexone treatment: a quantitative synthesis.

Mental Retardation and Developmental Disabilities Research Reviews

10(3), pp. 193-200

Read Abstract (New Window)

Taylor D. et al. (1991)

Effect of naltrexone upon self-injurious behavior, learning and activity: a case study.

Pharmacology Biochemistry and Behavior

40(1), pp. 79-82

Read Abstract (New Window)

Walters A. S. et al. (1990)

A case report of naltrexone treatment of self-injury and social withdrawal in autism.

Journal of Autism and Developmental Disorders

20(2), pp. 169-176

Read Extract (New Window)

White T. , Schultz S. K. (2000)

Naltrexone treatment for a 3-year old boy with self-injurious behaviour.

American Journal of Psychiatry

157 pp. 1574-1822

Read Full (New Window)

Willemsen-Swinkels S. H. et al. (1999)

Brief report: six months continuation treatment in naltrexone-responsive children with autism: an open-label case-control design.

Journal of Autism and Developmental Disorders

29(2), pp. 167-169

Read Abstract (New Window)

Willemsen-Swinkels S. H. et al. (1995)

Failure of naltrexone hydrochloride to reduce self-injurious and autistic behaviour in mentally retarded adults: double-blinded placebo-controlled studies.

Archives of General Psychiatry

52(9), pp. 766-773

Read Abstract (New Window)

Willemsen-Swinkels S. H. et al. (1995)

Placebo-controlled acute dosage naltrexone study in young autistic children.

Psychiatry Research

58(3), pp. 203-215

Read Abstract (New Window)

Willemsen-Swinkels S. H. , Buitelaar J. K. , van Engeland H. (1996)

The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study.

Biological Psychiatry

39(12), pp. 1023-1031

Read Abstract (New Window)

Williams P. G. et al. (2001)

Brief report: case reports on naltrexone use in children with autism: controlled observations regarding benefits and practical issues of medication management.

Journal of Autism and Developmental Disorders

31(1), pp. 103-108

Read Abstract (New Window)

Zingarelli G. et al. (1992)

Clinical effects of naltrexone on autistic behavior.

American Journal of Mental Retardation

97(1), pp. 57-63

Read Abstract (New Window)